Tricyclic antidepressants mechanism of action
Pro Research Analysisby 
Searched over 200M research papers
Tricyclic Antidepressants Mechanism of Action: Monoamine Reuptake Inhibition
Tricyclic antidepressants (TCAs) primarily work by inhibiting the reuptake of key neurotransmitters, especially noradrenaline (norepinephrine) and serotonin (5-hydroxytryptamine), at nerve endings in the brain. This action increases the levels of these neurotransmitters in the synaptic cleft, which is believed to improve mood and relieve symptoms of depression Horn1980Kocherga1977Stahl1998+2 MORE. The inhibition of monoamine reuptake is considered the classical and most well-known mechanism of TCAs.
Receptor Sensitivity and Neurotransmitter Modulation
Recent research suggests that, beyond immediate neurotransmitter reuptake inhibition, TCAs may also cause longer-term changes in the sensitivity of neurotransmitter receptors. These changes in receptor sensitivity may explain why the antidepressant effects of TCAs often take several weeks to become noticeable, even though neurotransmitter levels increase soon after starting treatment . Additionally, TCAs can influence the metabolism of neurotransmitters and the activity of enzymes that regulate ion transport and cyclic AMP metabolism, further affecting synaptic transmission .
Effects on Ion Channels and Membrane Activity
TCAs have surface-active properties that allow them to generate liquid membranes, which can alter the permeability of biogenic amines (such as adrenaline, noradrenaline, dopamine, and serotonin) and ions (potassium, sodium, and calcium) across nerve cell membranes. This membrane-modifying effect may play a significant role in their antidepressant action by affecting neurotransmitter and ion transport . TCAs also inhibit Na+, K+-ATPase activity, which can influence neuronal excitability .
NMDA Receptor Antagonism and Potassium Channel Modulation
In addition to their effects on monoamine neurotransmitters, TCAs can block N-methyl-D-aspartate (NMDA) receptors, which are involved in glutamatergic neurotransmission. This NMDA receptor antagonism is similar to the action of zinc and may contribute to the therapeutic effects of TCAs, especially in conditions like chronic pain and fibromyalgia Reynolds1988Lawson2002. TCAs may also modulate potassium channels, further influencing neuronal signaling .
Anticholinergic and Other Receptor Effects
TCAs exhibit anticholinergic activity by blocking muscarinic acetylcholine receptors, which can lead to side effects such as dry mouth, constipation, and blurred vision. The strength of this effect varies among different TCAs, depending on their chemical structure Shein1978Feighner1999. TCAs also block histaminic and alpha1-adrenergic receptors, contributing to other side effects like sedation and dizziness .
Modulation of Cys-Loop Receptors
TCAs can inhibit Cys-loop receptors, such as 5-HT3A receptors, by acting on both open and closed states of these ion channels. This inhibition is noncompetitive and concentration-dependent, affecting the flow of ions and the excitability of neurons .
Conclusion
Tricyclic antidepressants act through multiple mechanisms, with the primary effect being the inhibition of noradrenaline and serotonin reuptake. They also modulate neurotransmitter receptor sensitivity, alter membrane and ion channel function, block NMDA receptors, and exhibit anticholinergic and antihistaminic effects. These combined actions contribute to both their therapeutic benefits and side effect profiles Nagappa2003Horn1980Kocherga1977+7 MORE.
Sources and full results
Most relevant research papers on this topic